Scottish Start-up UB Pharma to Deliver UPS Drug Targets

LONDON – A £9.3 million (US$14.43 million) publicly funded ubiquitin research program has overcome difficulties in drugging those key protein recycling targets, leading to the formation of UB Pharma Ltd., which has now set out to raise £4 million to £6 million to take the lead candidates through to the clinic.